Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

Clinical trial NCT06501586 · COMPLETED

Trial details

NCT number: NCT06501586
Sponsor: Suzhou Sanegene Bio Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension,Essential

Start date: 2024-07-31
Primary completion: 2025-04-07
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.